Misplaced Pages

David Bennett (neurologist)

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Neurologist

David A Bennett is a neurologist, Director of the Rush Alzheimer's Disease Center (RADC), and the Robert C Borwell Professor of Neurology at Rush University Medical Center. Bennett is also visiting professor, Instituto de Assistencia Medica ao Servidor Publico Estadual (IAMSPE), São Paulo, Brazil.

Bennett was the recipient of the 2018 Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases "in recognition of methods he developed with colleagues to measure de novo synthesis of amyloid-beta (Abeta)."

Bennett is the principal investigator of the National Institute on Aging (NIA) funded Religious Orders Study (ROS) and the Rush Memory and Aging Project (MAP). Biospecimens and data from ROS and MAP are used as part of the NIH funded Accelerating Medicines Partnership for Alzheimer's Disease (AMP-AD). He also leads the Pathology Alzheimer's and Related Dementias Study (PARDoS) in the state of São Paulo Brazil.

Selected publications

References

  1. "David A. Bennett, MD". Rush University. Retrieved December 6, 2023.
  2. "RUSH Alzheimer's Disease Center". Rush University. Retrieved December 6, 2023.
  3. "PARDoS Staff". Rush University Medical Center. Retrieved December 6, 2023.
  4. "Past Recipients Making a Difference". The Potamkin Prize. Retrieved December 6, 2023.
  5. Hurley, Dan (2019). "Potamkin Prize recipient Randall J. Bateman, MD, FAAN, discusses his trajectory from life on a farm to leading major clinical trials in Alzheimer's disease". Neurology Today. Vol. 19, no. 16.
  6. "Religious Orders Study". NIH RePORT.
  7. "Epidemiologic Study of Neural Reserve and Neurobiology of Aging". NIH RePORT.
  8. "Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets". NIH RePORT.
  9. "Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets". National Institute on Aging.
  10. "Contributing Teams". Agora.
  11. "Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil". NIH RePORT.
Categories: